证券记录 · 已归档季度
CDNA
CareDx, Inc · Healthcare · Medical - Diagnostics & Research
14被追踪持有人
0Δ持有人
12.01M持有股份
$257.21M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +1.6% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q4 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 95 | +15 | 33.94M | $966.70M | +15 | — |
| Q1 2026 | 83 | +3 | 34.73M | $602.98M | +6 | −3 |
| Q4 2025 | 80 | +2 | 35.05M | $660.43M | +2 | — |
| Q3 2025 | 16 | -1 | 19.38M | $281.84M | — | −1 |
| Q2 2025 | 14 | -2 | 18.42M | $359.99M | — | −2 |
| Q1 2025 | 13 | -1 | 10.08M | $178.96M | — | −1 |
| Q4 2024 | 14 | 0 | 12.01M | $257.21M | +1 | −1 |
| Q3 2024 | 13 | +2 | 9.17M | $286.29M | +2 | — |
| Q2 2024 | 11 | — | 12.97M | $201.49M | — | — |
持有人 · Q4 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (被动) | 2.66M | — | $56.93M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | ARK Investment Management ✦ | 2.41M | -19.4% | $51.58M | 0.4% | ▼ Trim | 3 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 1.43M | +15.9% | $30.66M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.23M | +0.5% | $26.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 1.23M | +0.5% | $26.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 1.15M | -15.5% | $24.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 1.15M | -15.5% | $24.60M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Millennium Management ✦ | 621.31K | +37.8% | $13.30M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 9 | AQR Capital Management ✦ | 547.27K | +65.9% | $11.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 547.27K | +65.9% | $11.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 547.27K | +65.9% | $11.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 547.27K | +65.9% | $11.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 510.04K | +23.9% | $10.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 468.84K | +50.0% | $10.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 465.67K | +81.5% | $9.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Marshall Wace ✦ | 289.46K | -21.4% | $6.20M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 289.46K | -21.4% | $6.20M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 289.46K | -21.4% | $6.20M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 165.36K | -14.6% | $3.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 165.36K | -14.6% | $3.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 165.36K | -14.6% | $3.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 165.36K | -14.6% | $3.54M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | Arrowstreet Capital ✦ | 34.16K | 新增 | $731,408 | 0.0% | New | 1 | SEC ↗ |
| 24 | T. Rowe Price ✦ | 27.12K | +12.5% | $581,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $731,408 | 0.0% |
已清仓
| Gotham Asset Management | $262,446 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 189 持有人, 52.20M 股份, $899.83M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q4 2024 ·
方法论 ·
通过API获取此数据